CellaVision

CellaVision is an innovative, global medical technology company that develops and sells its own leading systems for routine analysis of blood and other body fluids in health care services.

The analyses often constitute important reference data for fast and correct diagnosis of illnesses such as viral and bacterial infections and cancers. CellaVision's products rationalize manual laboratory work, and secure and support effective workflows and skills development within and between hospitals. In 2017 sales were SEK 309 million. Sales continue to increase, with a growth target of at least 15 % per year over an economic cycle. CellaVision's registered office is in Lund, Sweden and the company has subsidiaries in Europe, USA, Canada, Japan, Republic of Korea, United Arab Emirates, Australia and Brazil. The share is listed on the OMX Stockholm, Small Cap list.

We have great benefits

• Flexible working hours
• Free breakfast
• 30 days of paid holiday
• High quality on site restaurants & café
• Work-life balance
• Open and collaborative environment
• Strong focus on continuous learning and development
• Inclusive
• Leading edge technology and innovation